Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Goodwill (2022 - 2025)

Collegium Pharmaceutical has reported Goodwill over the past 4 years, most recently at $145.9 million for Q4 2025.

  • Quarterly results put Goodwill at $145.9 million for Q4 2025, down 10.11% from a year ago — trailing twelve months through Dec 2025 was $145.9 million (down 10.11% YoY), and the annual figure for FY2025 was $145.9 million, down 10.11%.
  • Goodwill for Q4 2025 was $145.9 million at Collegium Pharmaceutical, roughly flat from $145.9 million in the prior quarter.
  • Over the last five years, Goodwill for COLL hit a ceiling of $162.3 million in Q4 2024 and a floor of $130.1 million in Q2 2022.
  • Median Goodwill over the past 4 years was $133.9 million (2023), compared with a mean of $139.2 million.
  • Biggest five-year swings in Goodwill: increased 21.27% in 2024 and later dropped 10.11% in 2025.
  • Collegium Pharmaceutical's Goodwill stood at $133.7 million in 2022, then rose by 0.12% to $133.9 million in 2023, then grew by 21.27% to $162.3 million in 2024, then fell by 10.11% to $145.9 million in 2025.
  • The last three reported values for Goodwill were $145.9 million (Q4 2025), $145.9 million (Q3 2025), and $147.9 million (Q2 2025) per Business Quant data.